EP1238971A4 - Substituierte guanidin-derivate - Google Patents

Substituierte guanidin-derivate

Info

Publication number
EP1238971A4
EP1238971A4 EP00979980A EP00979980A EP1238971A4 EP 1238971 A4 EP1238971 A4 EP 1238971A4 EP 00979980 A EP00979980 A EP 00979980A EP 00979980 A EP00979980 A EP 00979980A EP 1238971 A4 EP1238971 A4 EP 1238971A4
Authority
EP
European Patent Office
Prior art keywords
ring
optionally substituted
single bond
guanidine derivatives
substituted guanidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00979980A
Other languages
English (en)
French (fr)
Other versions
EP1238971A1 (de
Inventor
Masahumi Kitano
M Yuri
Naohito Ohashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of EP1238971A1 publication Critical patent/EP1238971A1/de
Publication of EP1238971A4 publication Critical patent/EP1238971A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP00979980A 1999-12-16 2000-12-07 Substituierte guanidin-derivate Withdrawn EP1238971A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP35693099 1999-12-16
JP35693099 1999-12-16
JP2000162669 2000-05-31
JP2000162669 2000-05-31
PCT/JP2000/008669 WO2001044186A1 (fr) 1999-12-16 2000-12-07 Derives de guanidine substitues

Publications (2)

Publication Number Publication Date
EP1238971A1 EP1238971A1 (de) 2002-09-11
EP1238971A4 true EP1238971A4 (de) 2003-02-26

Family

ID=26580525

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00979980A Withdrawn EP1238971A4 (de) 1999-12-16 2000-12-07 Substituierte guanidin-derivate

Country Status (4)

Country Link
US (1) US6734205B2 (de)
EP (1) EP1238971A4 (de)
AU (1) AU1733701A (de)
WO (1) WO2001044186A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
JP4826983B2 (ja) * 2005-02-16 2011-11-30 トーアエイヨー株式会社 シクロヘプタ［ｂ］ピリジン−３−カルボニルグアニジン誘導体およびそれを含有する医薬品

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
EP0803501A1 (de) * 1996-04-24 1997-10-29 Sumitomo Pharmaceuticals Company, Limited Substituierte Guanidin Derivate und ihre Verwendung als Na+/H+ Austausch Inhibitoren
JPH10237073A (ja) * 1996-02-02 1998-09-08 Sumitomo Pharmaceut Co Ltd 新規な置換グアニジン誘導体およびその製法
US5977100A (en) * 1996-02-02 1999-11-02 Sumitomo Pharmaceuticals Company, Limited Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3154520A (en) * 1959-10-01 1964-10-27 Rohm & Haas Boron-substituted silanes and polymers therefrom
AR207752A1 (es) 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
US5084466A (en) 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
US6169107B1 (en) * 1993-04-28 2001-01-02 Sumitomo Pharmaceutical Co., Ltd. Indoloylguanidine derivatives
CA2121391A1 (en) * 1993-04-28 1994-10-29 Atsuyuki Kojima Indoloylguanidine derivatives
IL109570A0 (en) 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
CA2160600A1 (en) 1994-10-18 1996-04-19 Masahumi Kitano Indoloylguanidine derivatives
PT891325E (pt) 1996-03-29 2002-07-31 Searle & Co Derivados do acido fenilpropanoico para-substituido como antagonistas de integrina
JPH10310582A (ja) 1997-03-13 1998-11-24 Sankyo Co Ltd ピペリジン環縮合カルバペネム化合物
WO1999055690A1 (en) 1998-04-24 1999-11-04 Fujisawa Pharmaceutical Co., Ltd. Guanidine derivatives
TW462964B (en) 1998-05-26 2001-11-11 Sumitomo Pharma Guanidine derivatives for the treatment and prevention of disorders caused by inhibiting hyperactivity of Na/H exchange transport system and process for producing the same
WO2000044707A1 (fr) 1999-01-27 2000-08-03 Sumitomo Pharmaceuticals Company, Limited Nouveaux derives de guanidine substitues et leur procede de preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
JPH10237073A (ja) * 1996-02-02 1998-09-08 Sumitomo Pharmaceut Co Ltd 新規な置換グアニジン誘導体およびその製法
US5977100A (en) * 1996-02-02 1999-11-02 Sumitomo Pharmaceuticals Company, Limited Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
EP0803501A1 (de) * 1996-04-24 1997-10-29 Sumitomo Pharmaceuticals Company, Limited Substituierte Guanidin Derivate und ihre Verwendung als Na+/H+ Austausch Inhibitoren

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0144186A1 *

Also Published As

Publication number Publication date
US20030018056A1 (en) 2003-01-23
AU1733701A (en) 2001-06-25
EP1238971A1 (de) 2002-09-11
WO2001044186A1 (fr) 2001-06-21
US6734205B2 (en) 2004-05-11

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CA2358998A1 (en) Substituted bicyclic derivatives useful as anticancer agents
PT928788E (pt) Compostos farmaceuticamente activos
EP1103552A4 (de) Benzothiepin-derivate, verfahren zu ihrer herstellung und ihre verwendungen
NO942953D0 (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
SE9904508D0 (sv) New compounds
NZ512883A (en) 2-oxoquinoline compounds and medicinal uses thereof
DE68925223T2 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
CA2083639A1 (en) Substituted phenyl phenol leukotriene antagonists
EP0712844A4 (de) Neue kondensierte carbonsäureverbindung oder ihr salz und ihre medizinische verwendung
NO20022552D0 (no) Nye benzotiadiazinderivater, deres fremstilling og farmasöytiske sammensetninger inneholdende det samme
CA2300289A1 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
EP1238971A4 (de) Substituierte guanidin-derivate
MXPA01007705A (es) Derivado de benzamida y medicamento que lo contiene.
NO20013601L (no) Nye morfolinobenzamidsalter
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
AU4732096A (en) Remedy for pulmonary heart
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
FI950209A (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
JO2240B1 (en) Method for preparing dithylidene derivatives
PT83307B (en) Spirobenzofuran-2 (3h),1'-cycloheptanes a process and interme diates for their preparation and their use as medicaments
DK0452809T3 (da) Terapautisk middel til pollakisuri, urgeinkontinens eller urininkontinens omfattende alfa-phenyl-alfa-pyridylalkansyrederivater

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020702

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030115

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 498/06 B

Ipc: 7C 07F 9/572 B

Ipc: 7C 07D 487/06 B

Ipc: 7A 61K 31/404 A

Ipc: 7C 07D 209/42 B

Ipc: 7C 07H 17/02 B

Ipc: 7C 07D 471/06 B

Ipc: 7C 07D 209/90 B

Ipc: 7C 07D 209/56 B

Ipc: 7A 61K 31/407 B

17Q First examination report despatched

Effective date: 20040127

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040807